1971
DOI: 10.1016/s0021-9258(18)62498-6
|View full text |Cite
|
Sign up to set email alerts
|

On the Mode of Action of Lipid-lowering Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

1971
1971
1980
1980

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 68 publications
(4 citation statements)
references
References 30 publications
0
4
0
Order By: Relevance
“…did not alter the incorporation of labeled leucine or uridine into protein or RNA, respectively, in the presence or absence of aldosterone (Table II). It did, however, block the increase in both weight percentage of membrane phospholipid polyunsaturated fatty acids and [l4C]acetate incorporation into lipid usually seen after aldosterone action (Fig- others it is known that inhibits acetyl-CoA carboxylase in vitro by competitively binding to the isocitrate-activating site (Maragoudakis, 1970;Maragoudakis and Hankin, 1971). The drug, however, does not inhibit a number of glycolytic, citric acid cycle, and fatty acid synthesis enzymes (Maragoudakis, 1969).…”
Section: Discussionmentioning
confidence: 98%
See 3 more Smart Citations
“…did not alter the incorporation of labeled leucine or uridine into protein or RNA, respectively, in the presence or absence of aldosterone (Table II). It did, however, block the increase in both weight percentage of membrane phospholipid polyunsaturated fatty acids and [l4C]acetate incorporation into lipid usually seen after aldosterone action (Fig- others it is known that inhibits acetyl-CoA carboxylase in vitro by competitively binding to the isocitrate-activating site (Maragoudakis, 1970;Maragoudakis and Hankin, 1971). The drug, however, does not inhibit a number of glycolytic, citric acid cycle, and fatty acid synthesis enzymes (Maragoudakis, 1969).…”
Section: Discussionmentioning
confidence: 98%
“…It did, however, block the increase in both weight percentage of membrane phospholipid polyunsaturated fatty acids and [l4C]acetate incorporation into lipid usually seen after aldosterone action (Fig- others it is known that inhibits acetyl-CoA carboxylase in vitro by competitively binding to the isocitrate-activating site (Maragoudakis, 1970;Maragoudakis and Hankin, 1971). The drug, however, does not inhibit a number of glycolytic, citric acid cycle, and fatty acid synthesis enzymes (Maragoudakis, 1969). Results from rat mammary gland cell culture also indicate an effect of on acetyl-CoA carboxylase; although production of [14C]CC>2 and labeling of nonlipid material from [14C]acetate remains unchanged, lipogenesis is greatly reduced (Maragoudakis, 1971).…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations